Bosun Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,294
Closed -$206K 217
2025
Q1
$206K Buy
2,294
+94
+4% +$8.78K 0.09% 185
2024
Q4
$219K Buy
2,200
+271
+14% +$27.9K 0.1% 177
2024
Q3
$219K Buy
1,929
+73
+4% +$8.67K 0.1% 168
2024
Q2
$230K Sell
1,856
-5,215
-74% -$672K 0.14% 139
2024
Q1
$933K Sell
7,071
-713
-9% -$87.9K 0.53% 48
2023
Q4
$849K Buy
7,784
+984
+14% +$102K 0.84% 27
2023
Q3
$700K Sell
6,800
-500
-7% -$53.9K 0.76% 32
2023
Q2
$842K Buy
+7,300
New +$829K 0.83% 26

Other funds holding MRK

Bosun Asset Management's MRK Position: Q2 2025 in Review

Bosun Asset Management sold out of Merck (MRK) in Q2 2025, closing a stake of 2,294 shares — an estimated $206K sold.

Bosun Asset Management first reported a position in MRK in Q2 2023 and held it in 8 quarters. The position peaked at $933K in Q1 2024. 3,328 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Bosun Asset Management reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Bosun Asset Management sold 2,294 Merck shares in Q2 2025, an estimated $206K.
  • Bosun Asset Management first reported a position in Merck in Q2 2023 and held it in 8 quarters.
  • Bosun Asset Management's Merck position peaked at $933K in Q1 2024.
  • 3,328 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Bosun Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.